옵션 체인은 다양한 행사가격과 만기일에 대한 BuzzFeed의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 BuzzFeed에 대한 시장 심리를 평가합니다..

BuzzFeed (NASDAQ:BZFD) 주식, 옵션 체인

BuzzFeed

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Buzzfeed-Photo by Matt Haughey via Flickr

Earnings

News

WIIM

Movers

BZFD

미국의 뉴스 및 엔터테인먼트 웹사이트 기업인 버즈피드(NASDAQ:BZFD)의 주가는 예상보다 나은 2분기 주당 순이익을 발표한 후 월요일 시간외 거래에서 20% 이상 상승했다.

버즈피드의 주식이 예상보다 좋은 2분기 이익 발표 후 20% 이상 급등: 그 이유는?

BuzzFeed Inc

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) with a Buy and maintains $102 price target.

Price Target

Reiteration

Analyst Ratings

VKTX

HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target

<a href="https://www.youtube.com/watch?v=6oJb0QSEwpo" title="https://www.youtube.com/watch?v=6oJb0QSEwpo">https://www.youtube.com/watch?v=6oJb0QSEwpo</a>

Macro Economic Events

Economics

Federal Reserve

Fed Chair Powell Says Open To The Possibility That Tariffs Translating To Inflation Will Be More, Or Less Than We Think, Watching To See What Shows Up In Measured Inflation

<a href="https://www.bloomberg.com/news/articles/2025-06-25/trump-administration-urges-appeals-court-to-back-tariff-power-mcc1zd5s?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-25/trump-administration-urges-appeals-court-to-back-tariff-power-mcc1zd5s?embedded-checkout=true</a>

General

'Trump Administration Urges Appeals Court to Back Tariff Power'- Bloomberg

Keefe, Bruyette &amp; Woods analyst Christopher Mcgratty maintains First Financial Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFBC#NASDAQ">FFBC</a>) with a Market Perform and raises the price target from $30 to $32.

FFBC

Keefe, Bruyette & Woods Maintains Market Perform on First Financial Bancorp, Raises Price Target to $32

Canaccord Genuity analyst Brian McNamara maintains Spectrum Brands Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) with a Buy and lowers the price target from $89 to $77.

Canaccord Genuity Maintains Buy on Spectrum Brands Holdings, Lowers Price Target to $77

Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) has outperformed the market over the past 20 years by 3.48% on an annualized basis producing an average annual return of 11.91%. Currently, Take-Two Interactive has a market capitalization of $44.42 billion. 
Buying $100 In TTWO: If an investor had bought $100 of TTWO stock 20 years ago, it would be worth $960.25 today based on a price of $242.86 for TTWO at the time of writing.
<h3>Take-Two Interactive's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750862734_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

TTWO

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Benchmark analyst David Williams reiterates IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) with a Buy and maintains $50 price target.

IONQ

Benchmark Reiterates Buy on IonQ, Maintains $50 Price Target

<a href="https://www.youtube.com/watch?v=2PnYYb_xj3U">https://www.youtube.com/watch?v=2PnYYb_xj3U</a>
&nbsp;

Biotech

BNTX

MRNA

NVAX

Trump Nominee For U.S. CDC Director Monarez Tells Senate Panel She Has Not Seen A Causal Link Between Vaccines And Autism

Goldman Sachs is cautious about Kraft Heinz Co's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) review of strategic alternatives.
The process could lend upside, but the firm&#8217;s analysts are mindful of the company's "sales declines and market share losses across key categories.&#8221;
The Kraft Heinz Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/63875da89f15fd0001b84e16/leah-jordan">Analyst Leah Jordan</a> upgraded the rating from Sell to Neutral, while raising the price target from $25 to $27.
The Kraft Heinz Thesis: Krafty has been eager to "unlock shareholder value," Jordan said in the upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
She added that if Kraft Heinz's largest shareholder, Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), sells its position, the funds could be used for share buybacks.
Some press reports suggest coffee and Oscar Mayer are divestiture options, the analyst stated.
"KHC has a portfolio of well-known brands, thus we acknowledge there are potential actions which could be accretive to shareholders," she further wrote.
Price Action: Shares of Kraft Heinz had declined by 0.83% to $25.82 at the time of publication on Wednesday.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/insights/analyst-ratings/25/06/45946624/canaan-stock-a-deep-dive-into-analyst-perspectives-8-ratings">Kraft Heinz Bans Artificial Colors In US Products, Eyes Full Phaseout By 2027</a></li>
</ul>
Image: Shutterstock

Analyst Color

Upgrades

This Kraft Heinz Analyst Is No Longer Bearish Amid Review Of Strategic Alternatives

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) with a Buy and maintains $14 price target.

PHIO

HC Wainwright & Co. Reiterates Buy on Phio Pharma, Maintains $14 Price Target

Susquehanna analyst Joseph Stauff maintains Liberty Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWONK#NASDAQ">FWONK</a>) with a Positive and raises the price target from $115 to $121.

FWONK

Susquehanna Maintains Positive on Liberty Media, Raises Price Target to $121

<a href="https://www.youtube.com/watch?v=6oJb0QSEwpo">https://www.youtube.com/watch?v=6oJb0QSEwpo</a>
&nbsp;

Fed Chair Powell Says Bond Market Functioning Well; Inflation Expectations Have Come Down A Bit From April; Asked About Recent Weakness In Dollar, Says Markets Have Been Digesting An Unusually Challenging Set Of Circumstance

High-net-worth (HNW) individuals, often with investable assets exceeding $1 million, face complex considerations when planning for retirement. In 2025, affluent retirees are increasingly focused on strategies that aim to preserve wealth, support their lifestyles, and create lasting legacies amidst market fluctuations and changing tax regulations. A certain type of financial professional, the tax-focused retirement advisor, is gaining prominence by offering integrated approaches to tax-efficient investing, sustainable withdrawal strategies, and estate planning.
Broker-dealers, who primarily sell investment products and earn fees, and non-fiduciary advisors (those not bound to act solely in the client's best interest) are generally prohibited from providing specific tax advice unless they hold tax credentials. In 2023, there were approximately 625,000 registered brokers in the U.S [a]., many of whom face these restrictions.&nbsp; At the same time, it's estimated there were fewer than 90,000 fiduciary financial advisors who potentially offer tax planning.&nbsp; An easier way to think about it, for every 10 "advisors" that retirees may be working with, only 1 of those is likely to offer tax planning. [b,c]
These key areas may assist HNW retirees in navigating their financial futures.
<h2 class="wp-block-heading"><a></a>Tax-Efficient Investing: Aiming to Preserve Wealth</h2>
Taxes can potentially reduce portfolio returns if not carefully and proactively managed. With diverse income sources, individuals often seek ways to minimize tax liabilities while pursuing investment growth. Strategies such as Roth IRAs, municipal bonds, and tax-loss harvesting are commonly explored to potentially enhance after-tax outcomes. Other strategies involve an approach that moves assets from a taxable account type into a tax-free option.&nbsp; These strategies may be initially overlooked as some taxes will be paid during the move in most cases; however, with some strategies, there may be ways to better reduce your tax bill in the long run.
"Tax-focused advisors aim to prioritize long-term tax efficiency as a core component of retirement planning," says Christopher Dixon, Co-Founder of Oxford Advisory Group. "By considering options like Roth accounts for tax-free growth or municipal bonds for tax-exempt income, advisors seek to potentially reduce tax exposure." For example, 36.1 million U.S. households utilize Roth IRAs, which may offer tax-free withdrawals after age 59½, making them a popular tool for HNW retirees [1]. One should also monitor potential tax policy changes in 2025 to help keep strategies aligned with current regulations.
<h2 class="wp-block-heading"><a></a>Sustainable Withdrawal Strategies: Supporting Lifestyle and Longevity</h2>
It can be a tricky balance to maintain an affluent lifestyle while ensuring wealth lasts through not just retirement, but survives into an estate to pass down. Research suggests these individuals reduce spending by approximately 0.35% annually, highlighting the need for carefully designed withdrawal plans [2]. Approaches like the 4% rule or bucket strategies are often considered to balance liquidity and growth, though with factors like inflation, taxes, and recent market swings, these tactics may be outdated.
"Flexible withdrawal plans aim to adapt to market conditions and individual needs," Dixon notes. "By potentially drawing from taxable, tax-deferred, and tax-free accounts, you may be able to have more options to manage your tax rate." Such strategies may help retirees manage their income efficiently, potentially supporting both current lifestyles and long-term financial goals.
<h2 class="wp-block-heading"><a></a>Estate and Legacy Planning: Crafting a Lasting Legacy</h2>
Estate planning is a priority for retirees who seek to transfer wealth efficiently to heirs or charitable causes. With 70% of individuals with assets over $1 million aiming to minimize estate taxes [3], strategies like trusts, life insurance, or qualified charitable distributions (QCDs) are often explored to potentially reduce tax burdens and align with personal values.
"Estate planning aims to blend tax strategy with legacy goals," says Dixon. "Tools like QCDs, which allow donations up to $108,000 annually from IRAs for those over 70½, can potentially lower taxable income while supporting philanthropy." By considering these options, tax-focused advisors aim to help clients protect assets and facilitate smooth wealth transfers, potentially preserving wealth for future generations.
<h2 class="wp-block-heading"><a></a>The Role of Tax-Focused Retirement Advisors</h2>
Tax-focused retirement advisors aim to offer a comprehensive approach, integrating tax planning, withdrawal strategies, and estate planning to address the unique needs of retirees. As financial complexities grow in 2025, their experience seeks to provide clarity and alignment with clients' goals. For HNW individuals exploring retirement options, consulting a tax-focused advisor may offer valuable insights into tailored strategies.
<hr class="wp-block-separator has-alpha-channel-opacity" />
<h2 class="wp-block-heading"><a></a>References</h2>
[1] Investment Company Institute, "The Role of IRAs in U.S. Households' Savings for Retirement, 2023," ICI Research Perspective, January 2024. [2] J.P. Morgan Asset Management, "2025 Retirement Planning Guide," J.P. Morgan, November 2024. [3] Fidelity Investments, "2024 High-Net-Worth Retirement Study," Fidelity, October 2024.
[a]The National Association of Personal Financial Advisors, www.napfa.org.
[b] "Financial Advisor Industry Statistics to Know," SmartAsset, March 2, 2025.
[c]"How Many Financial Advisors Are in the U.S.?" Finance Strategists, March 14, 2024.
&#x2A;&#x2A;

Opinion

Personal Finance

Why High-Net-Worth Retirees Are Turning To Tax-Focused Planning

Susquehanna analyst Bascome Majors maintains FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Positive and raises the price target from $290 to $295.

Susquehanna Maintains Positive on FedEx, Raises Price Target to $295

Glucotrack Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock traded higher on Wednesday, with a session volume of 15.91 million compared to the average of 81.7K, according to data <a href="https://www.benzinga.com/pro/feature/newsfeed" target="_blank" rel="noreferrer noopener">from Benzinga Pro</a>.
The diabetes-focused medical device company announced results on Wednesday from its completed first-in-human clinical study presented at the American Diabetes Association.
The study met all primary and secondary endpoints, demonstrating excellent accuracy with a Mean Absolute Relative Difference (MARD) of 7.7% across 122 matched pairs, a 99% data capture rate, and no procedure or device-related <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46093300/glucotrack-and-onetwo-analytics-present-positive-final-results-of-first-in-human-study-for-continu" rel="noreferrer noopener">serious adverse events</a>.
These findings validate the safety and performance of the company&#8217;s long-term, implantable Continuous Blood Glucose Monitor (CBGM). This monitor measures glucose from blood rather than interstitial fluid, eliminating the typical lag time associated with traditional continuous <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">glucose monitoring systems</a>.
Glucotrack leveraged OneTwo Analytics&#8217; next-generation artificial intelligence and machine learning-based analytics to evaluate the data and assess its clinical value.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/06/45719165/goldman-sachs-bullish-on-dexcom-and-insulet-as-diabetes-tech-surges" rel="noreferrer noopener">Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges</a>
Analysis using the Diabetes Technology Society Error Grid showed that 92% of the CBGM measurement values were in the green zone and none were recorded in the unsafe zones, demonstrating very high clinical accuracy compared to the reference blood glucose values.
The study, which was conducted in Brazil between December 13, 2024, and January 31, 2025, included ten participants with either Type 1 or Type 2 diabetes who were on intensive insulin therapy.
Following the device placement, each participant underwent inpatient observation for 4 days.
During this period, frequent blood sampling and glucose tolerance tests were conducted to assess device performance. Detailed analysis showed consistent performance during glucose tolerance testing with minimal lag time compared to venous blood samples.
The system remained in place throughout the study period and was removed at completion. Patients were then followed for seven days after removal.
Glucotrack expects to initiate a long-term early feasibility study in the third quarter of 2025. This study will evaluate safety and performance over an extended period, bringing the technology closer to its goal of providing patients with a less-intrusive alternative to continuous glucose monitoring.
Unlike traditional continuous glucose monitors, the Glucotrack CBGM is a fully implantable monitor. 
It consists of a sensor lead implanted into the subclavian vein and connected to subcutaneous electronics that communicate with a mobile application.
Designed for a three-year sensor life and continuous, accurate blood glucose monitoring, the system offers a more convenient and less intrusive solution for people with diabetes. It has no on-body wearable component and minimal calibration requirements.
The Glucotrack Continuous Blood Glucose Monitor is an Investigational Device.
Price Action: GCTK stock is up 59.9% at $9.93 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/06/46095881/daktronics-flashes-red-as-sales-disappoint-tariffs-loom-large" target="_blank" rel="noreferrer noopener">Daktronics Flashes Red As Sales Disappoint, Tariffs Loom Large</a></li>
</ul>
Photo: Shutterstock

Health Care

GCTK

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

BWS Financial analyst Hamed Khorsand maintains Garrett Motion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) with a Buy and maintains $14 price target.

BWS Financial Maintains Buy on Garrett Motion, Maintains $14 Price Target

RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) with a Outperform and lowers the price target from $16 to $12.

VSTM

RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $12

Susquehanna analyst Christopher Stathoulopoulos maintains Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) with a Positive and raises the price target from $27 to $30.

Susquehanna Maintains Positive on Carnival, Raises Price Target to $30

Barrington Research analyst Vincent Colicchio maintains TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) with a Outperform and maintains $156 price target.

Barrington Research Maintains Outperform on TD Synnex, Maintains $156 Price Target

RBC Capital analyst Brad Erickson reiterates Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Sector Perform and maintains $125 price target.

RDDT

RBC Capital Reiterates Sector Perform on Reddit, Maintains $125 Price Target

Press Releases

BuzzFeed, Inc. to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

BuzzFeed, Inc. Delivers Strong Q3 Financial Results

BuzzFeed, Inc. Announces Sale of First We Feast to an Affiliate of Soros Fund Management in $82.5 Million All-Cash Deal

BuzzFeed Declares War on "SNARF" and Announces a New Social Platform

BuzzFeed, Inc. Completes Strategic and Organizational Changes Following a Transformative 2024

Fintech

Real Estate

Fathom Holdings Appoints Highly Experienced Technology Industry Expert Adam Rothstein to Board of Directors

BuzzFeed, Inc. to Release First Quarter 2025 Financial Results on Thursday, May 8, 2025

BuzzFeed, Inc. Reports Q1 2025 Results and Continues to Advance High-Margin Revenue Lines and Strategy for Long-Term Growth

HuffPost Celebrates 20 Years Of Groundbreaking Digital-First Journalism

BuzzFeed, Inc. Secures $40 Million Loan

FTHM

RSVR

Antelope Enterprise Holdings Limited - Class A Ordinary Shares

Antelope Ent Hldgs

The Arena Group Holdings, Inc. Common Stock

Arena Group Holdings

Cheer Holding, Inc. - Class A Ordinary Share

Cheer Holding

DHI Group

Fangdd Network Group Ltd. - Class A Ordinary Shares

Fangdd Network Group

Phoenix New Media Limited American Depositary Shares, each representing 48 Class A ordinary shares.

Phoenix New Media

GIBO Holdings Limited - Class A Ordinary Shares

GIBO Holdings

Giftify

Intelligent Protection Management Corp. - Common Stock

Intelligent Protection

IZEA Worldwide

MoneyHero Limited - Class A Ordinary Shares

MoneyHero

Oriental Culture Holding LTD - Ordinary Shares

Oriental Culture Holding

PSQ Holdings

System1

So-Young International Inc. - American Depository Shares

So-Young Intl

Teads Holding

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

VS Media Holdings Limited - Class A Ordinary Shares

VS Media Holdings

Zedge

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

BuzzFeed

BuzzFeed (BZFD) 옵션

BuzzFeed (NASDAQ:BZFD) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌